J&J Takes Over at Emergent Vaccine Plant With Aid From Biden (1)

April 4, 2021, 4:09 AM

Johnson & Johnson, with help from the Biden administration, is taking over a Baltimore vaccine production facility that was the site of a major manufacturing error last month -- and moving production of material for a second company’s shot to minimize risk of another mistake.

J&J announced Saturday that it was “assuming full responsibility regarding the manufacturing of drug substance” at the Emergent BioSolutions Inc. plant. To facilitate that, the Department of Health and Human Services worked with AstraZeneca Plc. to move its production out of that plant so it can focus only on J&J, according to an HHS ...

To read the full article log in.

Learn more about a Bloomberg Law subscription